Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor	MAOA MAOB LOX LOXL1 LOXL2	4.13e-08	16	128	5	GO:0016641
GeneOntologyMolecularFunction	oxidoreductase activity, acting on the CH-NH2 group of donors	MAOA MAOB LOX LOXL1 LOXL2	1.44e-07	20	128	5	GO:0016638
GeneOntologyMolecularFunction	protein-lysine 6-oxidase activity	LOX LOXL1 LOXL2	2.55e-06	5	128	3	GO:0004720
GeneOntologyMolecularFunction	monoamine oxidase activity	MAOA MAOB	1.22e-04	3	128	2	GO:0097621
GeneOntologyMolecularFunction	aliphatic amine oxidase activity	MAOA MAOB	2.43e-04	4	128	2	GO:0052595
GeneOntologyBiologicalProcess	peptidyl-lysine oxidation	LOX LOXL1 LOXL2	2.37e-06	5	129	3	GO:0018057
GeneOntologyBiologicalProcess	external encapsulating structure organization	HPSE2 ADAMTS8 TGM1 ZNF469 LOX LOXL1 LOXL2 LPA PLG MMP15 ADAMTSL4	2.68e-05	379	129	11	GO:0045229
GeneOntologyBiologicalProcess	phenylethylamine metabolic process	MAOA MAOB	3.88e-05	2	129	2	GO:0042443
GeneOntologyBiologicalProcess	protein oxidation	LOX LOXL1 LOXL2	8.27e-05	14	129	3	GO:0018158
GeneOntologyBiologicalProcess	extracellular matrix organization	HPSE2 ADAMTS8 ZNF469 LOX LOXL1 LOXL2 LPA PLG MMP15 ADAMTSL4	1.32e-04	377	129	10	GO:0030198
GeneOntologyBiologicalProcess	extracellular structure organization	HPSE2 ADAMTS8 ZNF469 LOX LOXL1 LOXL2 LPA PLG MMP15 ADAMTSL4	1.35e-04	378	129	10	GO:0043062
GeneOntologyCellularComponent	extracellular matrix	HPSE2 BCAN ADAMTS8 LGALS4 COCH LOX LOXL1 MAMDC2 LOXL2 LPA PCSK6 LTBP3 BCAM PLG MMP15 ADAMTSL4	2.93e-06	656	129	16	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	HPSE2 BCAN ADAMTS8 LGALS4 COCH LOX LOXL1 MAMDC2 LOXL2 LPA PCSK6 LTBP3 BCAM PLG MMP15 ADAMTSL4	3.04e-06	658	129	16	GO:0030312
GeneOntologyCellularComponent	collagen-containing extracellular matrix	BCAN ADAMTS8 LGALS4 COCH LOX LOXL1 MAMDC2 LOXL2 LPA PCSK6 LTBP3 BCAM PLG ADAMTSL4	5.17e-06	530	129	14	GO:0062023
MousePheno	abnormal mammary gland connective tissue morphology	LPA PLG	6.02e-05	2	109	2	MP:0009507
MousePheno	ectropion	LPA PLG	6.02e-05	2	109	2	MP:0006164
MousePheno	esophageal ulcer	LPA PLG	6.02e-05	2	109	2	MP:0004547
MousePheno	duodenal ulcer	LPA PLG	6.02e-05	2	109	2	MP:0003273
MousePheno	perianal ulcer	LPA PLG	6.02e-05	2	109	2	MP:0005035
Domain	Lysyl_oxidase	LOX LOXL1 LOXL2	3.11e-06	5	128	3	IPR001695
Domain	LYSYL_OXIDASE	LOX LOXL1 LOXL2	3.11e-06	5	128	3	PS00926
Domain	Lysyl_oxidase_CS	LOX LOXL1 LOXL2	3.11e-06	5	128	3	IPR019828
Domain	Lysyl_oxidase	LOX LOXL1 LOXL2	3.11e-06	5	128	3	PF01186
Domain	Flavin_amine_oxidase	MAOA MAOB	1.39e-04	3	128	2	IPR001613
Domain	Argonaute_N	AGO2 AGO1	2.77e-04	4	128	2	IPR032474
Domain	Argonaute_Mid_dom	AGO2 AGO1	2.77e-04	4	128	2	IPR032473
Domain	ArgoL2	AGO2 AGO1	2.77e-04	4	128	2	IPR032472
Domain	ArgoN	AGO2 AGO1	2.77e-04	4	128	2	PF16486
Domain	ArgoMid	AGO2 AGO1	2.77e-04	4	128	2	PF16487
Domain	ArgoL2	AGO2 AGO1	2.77e-04	4	128	2	PF16488
Domain	DUF1785	AGO2 AGO1	4.60e-04	5	128	2	SM01163
Domain	IG	IL11RA LRFN1 OBSCN BCAN PTPRU SEMA4G PTK7 CD7 BCAM LILRA4	6.49e-04	421	128	10	SM00409
Domain	Ig_sub	IL11RA LRFN1 OBSCN BCAN PTPRU SEMA4G PTK7 CD7 BCAM LILRA4	6.49e-04	421	128	10	IPR003599
Domain	ArgoL1	AGO2 AGO1	6.87e-04	6	128	2	PF08699
Domain	ArgoL1	AGO2 AGO1	6.87e-04	6	128	2	IPR014811
Pathway	REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS	AGO2 AGO1 TNRC6A	7.24e-06	6	102	3	MM15083
Pathway	REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS	AGO2 AGO1 TNRC6A	1.26e-05	7	102	3	M46421
Pathway	REACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION	AGO2 AGO1 TNRC6A	2.99e-05	9	102	3	M27810
Pathway	REACTOME_REGULATION_OF_NPAS4_MRNA_TRANSLATION	AGO2 AGO1 TNRC6A	2.99e-05	9	102	3	M46436
Pathway	REACTOME_REGULATION_OF_CDH11_MRNA_TRANSLATION_BY_MICRORNAS	AGO2 AGO1 TNRC6A	4.25e-05	10	102	3	M48013
Pathway	REACTOME_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION	AGO2 AGO1 TNRC6A CTNND1	7.95e-05	32	102	4	M48012
Pathway	REACTOME_REGULATION_OF_NPAS4_GENE_EXPRESSION	AGO2 AGO1 TNRC6A	9.98e-05	13	102	3	M46434
Pathway	REACTOME_ELASTIC_FIBRE_FORMATION	LOX LOXL1 LOXL2 LTBP3	1.75e-04	39	102	4	MM14601
Pathway	REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY	AGO2 AGO1 TNRC6A	2.32e-04	17	102	3	M27788
Pathway	WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING	LOX LOXL1 LOXL2	2.32e-04	17	102	3	M39686
Pathway	REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS	LOX LOXL1 LOXL2	2.77e-04	18	102	3	M27164
Pathway	REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS	LOX LOXL1 LOXL2	2.77e-04	18	102	3	MM14882
Pathway	REACTOME_ELASTIC_FIBRE_FORMATION	LOX LOXL1 LOXL2 LTBP3	2.81e-04	44	102	4	M26969
Pathway	REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION	BCAN ADAMTS8 LOX LOXL1 LOXL2 TRAPPC4 LTBP3 PLG MMP15	3.22e-04	300	102	9	M610
Pathway	REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_APOPTOSIS	AGO2 AGO1 TNRC6A	3.28e-04	19	102	3	M48238
Pathway	BIOCARTA_DICER_PATHWAY	AGO2 AGO1	5.11e-04	5	102	2	M22079
Pathway	KEGG_MEDICUS_REFERENCE_SEROTONIN_METABOLISM	MAOA MAOB	5.11e-04	5	102	2	M47902
Pathway	REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION	BCAN LOX LOXL1 LOXL2 LPA LTBP3 PLG MMP15	5.62e-04	258	102	8	MM14572
Pubmed	Cadherin complexes recruit mRNAs and RISC to regulate epithelial cell signaling.	AGO2 TNRC6A CTNND1 PLEKHA7	6.47e-09	7	130	4	28877994
Pubmed	Functional consequence of fibulin-4 missense mutations associated with vascular and skeletal abnormalities and cutis laxa.	LOX LOXL1 LOXL2 LTBP3	1.29e-08	8	130	4	27339457
Pubmed	The copper dependent-lysyl oxidases contribute to the pathogenesis of pulmonary emphysema in chronic obstructive pulmonary disease patients.	LOX LOXL1 LOXL2	5.10e-08	3	130	3	28965583
Pubmed	The expression of lysyl-oxidase gene family members in myeloproliferative neoplasms.	LOX LOXL1 LOXL2	5.10e-08	3	130	3	23494965
Pubmed	Argonaute 2/RISC resides in sites of mammalian mRNA decay known as cytoplasmic bodies.	AGO2 AGO1 TNRC6A	5.10e-08	3	130	3	15908945
Pubmed	Lysyl oxidases: a novel multifunctional amine oxidase family.	LOX LOXL1 LOXL2	2.04e-07	4	130	3	11642359
Pubmed	Differential expression of the LOX family genes in human colorectal adenocarcinomas.	LOX LOXL1 LOXL2	2.04e-07	4	130	3	19724858
Pubmed	The C-terminal half of human Ago2 binds to multiple GW-rich regions of GW182 and requires GW182 to mediate silencing.	AGO2 AGO1 TNRC6A	5.08e-07	5	130	3	19324964
Pubmed	Human prion protein binds Argonaute and promotes accumulation of microRNA effector complexes.	AGO2 AGO1 TNRC6A	5.08e-07	5	130	3	22484317
Pubmed	Common polymorphisms in human lysyl oxidase genes are not associated with the adolescent idiopathic scoliosis phenotype.	LOX LOXL1 LOXL2	5.08e-07	5	130	3	21740577
Pubmed	Single nucleotide polymorphisms of microRNA machinery genes modify the risk of renal cell carcinoma.	AGO2 SEMA4G AGO1 SVIL	5.48e-07	18	130	4	19047128
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	FAM234B B4GALNT1 MARCHF6 EXT2 WDR25 H6PD PTK7 SCAP COCH LOX LOXL1 LOXL2 SVIL PRSS21 PLEKHA5 LTBP3 UNC93B1 DNASE2	5.70e-07	1201	130	18	35696571
Pubmed	Argonaute Utilization for miRNA Silencing Is Determined by Phosphorylation-Dependent Recruitment of LIM-Domain-Containing Proteins.	AGO2 AGO1 TNRC6A	1.77e-06	7	130	3	28683311
Pubmed	The C-terminal domains of human TNRC6A, TNRC6B, and TNRC6C silence bound transcripts independently of Argonaute proteins.	AGO2 AGO1 TNRC6A	1.77e-06	7	130	3	19383768
Pubmed	Functional dissection of the human TNRC6 (GW182-related) family of proteins.	AGO2 AGO1 TNRC6A	1.77e-06	7	130	3	19470757
Pubmed	Role of Rck-Pat1b binding in assembly of processing-bodies.	AGO2 AGO1 TNRC6A	1.77e-06	7	130	3	23535175
Pubmed	Lysyl oxidase (lox) gene deficiency affects osteoblastic phenotype.	LOX LOXL1 LOXL2	2.82e-06	8	130	3	19458888
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	LRFN1 BICRA OBSCN SLCO4A1 ARSG SCAP MDN1 PKD1 LRP3 DISP2 DEPDC5 LTBP3 LTK BCAM MAPKBP1 ZNF839	3.96e-06	1105	130	16	35748872
Pubmed	Localized LoxL3-Dependent Fibronectin Oxidation Regulates Myofiber Stretch and Integrin-Mediated Adhesion.	LOX LOXL1 LOXL2	4.22e-06	9	130	3	26954549
Pubmed	LIM-domain proteins, LIMD1, Ajuba, and WTIP are required for microRNA-mediated gene silencing.	AGO2 AGO1 TNRC6A	4.22e-06	9	130	3	20616046
Pubmed	TGF-beta1 induces the different expressions of lysyl oxidases and matrix metalloproteinases in anterior cruciate ligament and medial collateral ligament fibroblasts after mechanical injury.	LOX LOXL1 LOXL2	6.01e-06	10	130	3	23357697
Pubmed	mTORC1 activity regulates post-translational modifications of glycine decarboxylase to modulate glycine metabolism and tumorigenesis.	AGO2 AGO1 KHDRBS1 SVIL TNRC6A CTNND1 PLEKHA7 HNRNPR	9.50e-06	274	130	8	34244482
Pubmed	Defining a new role of GW182 in maintaining miRNA stability.	AGO2 TNRC6A	1.39e-05	2	130	2	23090477
Pubmed	Comparative immunocytochemical localization of lysyl oxidase (LOX) and the lysyl oxidase-like (LOXL) proteins: changes in the expression of LOXL during development and growth of mouse tissues.	LOX LOXL1	1.39e-05	2	130	2	15609098
Pubmed	Negative emotionality: monoamine oxidase B gene variants modulate personality traits in healthy humans.	MAOA MAOB	1.39e-05	2	130	2	19657584
Pubmed	Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence.	MAOA MAOB	1.39e-05	2	130	2	21971001
Pubmed	Structural properties of human monoamine oxidases A and B.	MAOA MAOB	1.39e-05	2	130	2	21971000
Pubmed	Reduced Expression of Argonaute 1, Argonaute 2, and TRBP Changes Levels and Intracellular Distribution of RNAi Factors.	AGO2 AGO1	1.39e-05	2	130	2	26242502
Pubmed	Persistent corneal haze after excimer laser photokeratectomy in plasminogen-deficient mice.	LPA PLG	1.39e-05	2	130	2	10634603
Pubmed	Thrombomodulin functions as a plasminogen receptor to modulate angiogenesis.	LPA PLG	1.39e-05	2	130	2	23943648
Pubmed	Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction.	LPA PLG	1.39e-05	2	130	2	7705657
Pubmed	Nucleocytoplasmic coagulation: an injury-induced aggregation event that disulfide crosslinks proteins and facilitates their removal by plasmin.	LPA PLG	1.39e-05	2	130	2	23041318
Pubmed	A novel role for plasmin-mediated degradation of opsonizing antibody in the evasion of host immunity by virulent, but not attenuated, Francisella tularensis.	LPA PLG	1.39e-05	2	130	2	19752236
Pubmed	Cognitive abnormalities and hippocampal alterations in monoamine oxidase A and B knockout mice.	MAOA MAOB	1.39e-05	2	130	2	23858446
Pubmed	Reduction of LOX- and LOXL2-mRNA expression in head and neck squamous cell carcinomas.	LOX LOXL2	1.39e-05	2	130	2	12820424
Pubmed	Up-regulation of the isoenzymes MAO-A and MAO-B in the human basal ganglia and pons in Huntington's disease revealed by quantitative enzyme radioautography.	MAOA MAOB	1.39e-05	2	130	2	21075085
Pubmed	Inhibition of Lysyl Oxidase and Lysyl Oxidase-Like Enzymes Has Tumour-Promoting and Tumour-Suppressing Roles in Experimental Prostate Cancer.	LOX LOXL1	1.39e-05	2	130	2	26804196
Pubmed	Plasminogen Tochigi: inactive plasmin resulting from replacement of alanine-600 by threonine in the active site.	LPA PLG	1.39e-05	2	130	2	6216475
Pubmed	Inhibition of Excessive Monoamine Oxidase A/B Activity Protects Against Stress-induced Neuronal Death in Huntington Disease.	MAOA MAOB	1.39e-05	2	130	2	25398695
Pubmed	Transcriptional regulation and multiple functions of MAO genes.	MAOA MAOB	1.39e-05	2	130	2	21359973
Pubmed	Tissue-type plasminogen activator is a neuroprotectant in the mouse hippocampus.	LPA PLG	1.39e-05	2	130	2	20440070
Pubmed	A central role for plasminogen in the inflammatory response to biomaterials.	LPA PLG	1.39e-05	2	130	2	15456492
Pubmed	Downregulation of lysyl oxidase and lysyl oxidase-like protein 2 suppressed the migration and invasion of trophoblasts by activating the TGF-β/collagen pathway in preeclampsia.	LOX LOXL2	1.39e-05	2	130	2	30804321
Pubmed	Staphylococcus aureus manganese transport protein C (MntC) is an extracellular matrix- and plasminogen-binding protein.	LPA PLG	1.39e-05	2	130	2	25409527
Pubmed	Restoration of thrombolytic potential in plasminogen-deficient mice by bolus administration of plasminogen.	LPA PLG	1.39e-05	2	130	2	8704243
Pubmed	Plasmin promotes foam cell formation by increasing macrophage catabolism of aggregated low-density lipoprotein.	LPA PLG	1.39e-05	2	130	2	23702659
Pubmed	Analysis of conserved active site residues in monoamine oxidase A and B and their three-dimensional molecular modeling.	MAOA MAOB	1.39e-05	2	130	2	11861643
Pubmed	human monoamine oxidase (hMAO) A and hMAO B inhibitors from Artemisia dracunculus L. herniarin and skimmin: human mononamine oxidase A and B inhibitors from A. dracunculus L.	MAOA MAOB	1.39e-05	2	130	2	32598328
Pubmed	Dengue virus-induced autoantibodies bind to plasminogen and enhance its activation.	LPA PLG	1.39e-05	2	130	2	22079981
Pubmed	Monoamine oxidase A and A/B knockout mice display autistic-like features.	MAOA MAOB	1.39e-05	2	130	2	22850464
Pubmed	Plasminogen deficiency differentially affects recruitment of inflammatory cell populations in mice.	LPA PLG	1.39e-05	2	130	2	9490683
Pubmed	Monoamine oxidase A gene polymorphism predicts adolescent outcome of attention-deficit/hyperactivity disorder.	MAOA MAOB	1.39e-05	2	130	2	17427196
Pubmed	Selective Interactions of O-Methylated Flavonoid Natural Products with Human Monoamine Oxidase-A and -B.	MAOA MAOB	1.39e-05	2	130	2	33212830
Pubmed	Comparison of the structural properties of the active site cavities of human and rat monoamine oxidase A and B in their soluble and membrane-bound forms.	MAOA MAOB	1.39e-05	2	130	2	18092818
Pubmed	Association study between antipsychotic-induced restless legs syndrome and polymorphisms of monoamine oxidase genes in schizophrenia.	MAOA MAOB	1.39e-05	2	130	2	20589923
Pubmed	Kringle 5 of human plasminogen suppresses hepatocellular carcinoma growth both in grafted and xenografted mice by anti-angiogenic activity.	LPA PLG	1.39e-05	2	130	2	16481742
Pubmed	Apolipoprotein(a) inhibits the conversion of Glu-plasminogen to Lys-plasminogen: a novel mechanism for lipoprotein(a)-mediated inhibition of plasminogen activation.	LPA PLG	1.39e-05	2	130	2	18983515
Pubmed	Plasminogen Regulates Fracture Repair by Promoting the Functions of Periosteal Mesenchymal Progenitors.	LPA PLG	1.39e-05	2	130	2	34378815
Pubmed	Plasmin generation plays different roles in the formation and removal of arterial and venous thrombus in mice.	LPA PLG	1.39e-05	2	130	2	11848464
Pubmed	Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice.	LPA PLG	1.39e-05	2	130	2	7586361
Pubmed	Plasminogen/plasmin modulates bone metabolism by regulating the osteoblast and osteoclast function.	LPA PLG	1.39e-05	2	130	2	21239499
Pubmed	Reciprocal regulation of LOX and LOXL2 expression during cell adhesion and terminal differentiation in epidermal keratinocytes.	LOX LOXL2	1.39e-05	2	130	2	19394199
Pubmed	Plasminogen-independent initiation of the pro-urokinase activation cascade in vivo. Activation of pro-urokinase by glandular kallikrein (mGK-6) in plasminogen-deficient mice.	LPA PLG	1.39e-05	2	130	2	10642175
Pubmed	Involvement of AGO1 and AGO2 in mammalian transcriptional silencing.	AGO2 AGO1	1.39e-05	2	130	2	16936728
Pubmed	Plasminogen mRNA induction in the mouse brain after kainate excitation: codistribution with plasminogen activator inhibitor-2 (PAI-2) mRNA.	LPA PLG	1.39e-05	2	130	2	12225871
Pubmed	Human eukaryotic initiation factor EIF2C1 gene: cDNA sequence, genomic organization, localization to chromosomal bands 1p34-p35, and expression.	AGO2 AGO1	1.39e-05	2	130	2	10534406
Pubmed	Localization of double-stranded small interfering RNA to cytoplasmic processing bodies is Ago2 dependent and results in up-regulation of GW182 and Argonaute-2.	AGO2 TNRC6A	1.39e-05	2	130	2	18946079
Pubmed	Monoamine oxidase a expression is vital for embryonic brain development by modulating developmental apoptosis.	MAOA MAOB	1.39e-05	2	130	2	21697081
Pubmed	Argonaute Family Protein Expression in Normal Tissue and Cancer Entities.	AGO2 AGO1	1.39e-05	2	130	2	27518285
Pubmed	Plasminogen deficiency suppresses pancreatic ductal adenocarcinoma disease progression.	LPA PLG	1.39e-05	2	130	2	37971174
Pubmed	The plasminogen activation system enhances brain and heart invasion in murine relapsing fever borreliosis.	LPA PLG	1.39e-05	2	130	2	9884337
Pubmed	Colonic Lesions, Cytokine Profiles, and Gut Microbiota in Plasminogen-Deficient Mice.	LPA PLG	1.39e-05	2	130	2	26473342
Pubmed	Increased baroreceptor response in mice deficient in monoamine oxidase A and B.	MAOA MAOB	1.39e-05	2	130	2	11834493
Pubmed	cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties.	MAOA MAOB	1.39e-05	2	130	2	3387449
Pubmed	Family-based case-control study of MAOA and MAOB polymorphisms in Parkinson disease.	MAOA MAOB	1.39e-05	2	130	2	17044053
Pubmed	Site-directed mutagenesis of monoamine oxidase A and B: role of cysteines.	MAOA MAOB	1.39e-05	2	130	2	8316221
Pubmed	Selection of mutant µplasmin for amyloid-β cleavage in vivo.	LPA PLG	1.39e-05	2	130	2	32694536
Pubmed	Association between monoamine oxidase gene polymorphisms and smoking behavior: A meta-analysis.	MAOA MAOB	1.39e-05	2	130	2	26051160
Pubmed	Three-dimensional structure of human monoamine oxidase A (MAO A): relation to the structures of rat MAO A and human MAO B.	MAOA MAOB	1.39e-05	2	130	2	16129825
Pubmed	Targeting of δ-catenin to postsynaptic sites through interaction with the Shank3 N-terminus.	SHANK3 CTNND1	1.39e-05	2	130	2	33115499
Pubmed	A spontaneous point mutation produces monoamine oxidase A/B knock-out mice with greatly elevated monoamines and anxiety-like behavior.	MAOA MAOB	1.39e-05	2	130	2	15272015
Pubmed	[The expression of P120 catenin in pancreatic carcinoma and the relationship between the T755G polymorphism of P120 catenin gene and pancreatic carcinoma].	CTNND1 PLEKHA7	1.39e-05	2	130	2	20193553
Pubmed	Promoter organization and activity of human monoamine oxidase (MAO) A and B genes.	MAOA MAOB	1.39e-05	2	130	2	1432104
Pubmed	GW182 interaction with Argonaute is essential for miRNA-mediated translational repression and mRNA decay.	AGO1 TNRC6A	1.39e-05	2	130	2	18345015
Pubmed	Role of plasminogen in propagation of scrapie.	LPA PLG	1.39e-05	2	130	2	16103174
Pubmed	Differential expression of oxidized/native lipoprotein(a) and plasminogen in human carotid and cerebral artery plaques.	LPA PLG	1.39e-05	2	130	2	21300353
Pubmed	Association of Polymorphic Variants in Argonaute Genes with Depression Risk in a Polish Population.	AGO2 AGO1	1.39e-05	2	130	2	36142498
Pubmed	Monoamine oxidases A and B gene polymorphisms in migraine patients.	MAOA MAOB	1.39e-05	2	130	2	15694196
Pubmed	Selective behaviors altered in plasminogen-deficient mice are reconstituted with intracerebroventricular injection of plasminogen.	LPA PLG	1.39e-05	2	130	2	11306011
Pubmed	Structural comparison of human monoamine oxidases A and B: mass spectrometry monitoring of cysteine reactivities.	MAOA MAOB	1.39e-05	2	130	2	12777388
Pubmed	Localization of regulatory elements mediating constitutive and cytokine-stimulated plasminogen gene expression.	LPA PLG	1.39e-05	2	130	2	12149246
Pubmed	Protective effects of plasmin(ogen) in a mouse model of Staphylococcus aureus-induced arthritis.	LPA PLG	1.39e-05	2	130	2	18311818
Pubmed	Localization of plasminogen in mouse hippocampus, cerebral cortex, and hypothalamus.	LPA PLG	1.39e-05	2	130	2	21190118
Pubmed	The influence of monoamine oxidase variants on the risk of betel quid-associated oral and pharyngeal cancer.	MAOA MAOB	1.39e-05	2	130	2	25389533
Pubmed	A physiological function for apolipoprotein(a): a natural regulator of the inflammatory response.	LPA PLG	1.39e-05	2	130	2	18997104
Pubmed	Growth and behavioral development in plasminogen gene-targeted mice.	LPA PLG	1.39e-05	2	130	2	10885855
Pubmed	Substrates but not inhibitors alter the redox potentials of monoamine oxidases.	MAOA MAOB	1.39e-05	2	130	2	11761322
Pubmed	Cellular density regulation of plasminogen gene expression in mouse hepatocytes.	LPA PLG	1.39e-05	2	130	2	12559391
Pubmed	Evidence for a genetic association between monoamine oxidase A and restless legs syndrome.	MAOA MAOB	1.39e-05	2	130	2	12136060
Pubmed	Polymorphisms and expression of genes encoding Argonautes 1 and 2 in autoimmune thyroid diseases.	AGO2 AGO1	1.39e-05	2	130	2	29256262
GeneFamily	Argonaute/PIWI family	AGO2 AGO1	5.73e-04	8	83	2	408
GeneFamily	Zinc fingers CXXC-type\|Methyl-CpG binding domain containing	SETDB1 BAZ2A	1.11e-03	11	83	2	1025
Coexpression	NABA_ECM_REGULATORS	HPSE2 ADAMTS8 TGM1 LOX LOXL1 LOXL2 LPA PCSK6 PLG MMP15 ADAMTSL4	3.09e-08	238	130	11	M3468
Coexpression	NABA_ECM_REGULATORS	HPSE2 ADAMTS8 TGM1 LOX LOXL1 LOXL2 LPA PCSK6 PLG MMP15 ADAMTSL4	3.66e-08	242	130	11	MM17062
Coexpression	DOUGLAS_BMI1_TARGETS_UP	IL11RA AGO2 PEG10 OBSCN SLCO4A1 TRMT6 LOXL1 LOXL2 PCSK6 TNRC6A IQSEC1 PLCB3 REEP4	4.77e-06	563	130	13	M15103
Coexpression	NABA_MATRISOME	HPSE2 BCAN ADAMTS8 SEMA4G LGALS4 TGM1 COCH LOX LOXL1 LOXL2 LPA PCSK6 LTBP3 PLG MMP15 ADAMTSL4 PLXNB3	1.05e-05	1008	130	17	MM17056
Coexpression	NABA_MATRISOME	HPSE2 BCAN ADAMTS8 SEMA4G LGALS4 TGM1 COCH LOX LOXL1 LOXL2 LPA PCSK6 LTBP3 PLG MMP15 ADAMTSL4 PLXNB3	1.33e-05	1026	130	17	M5889
Coexpression	NABA_MATRISOME_ASSOCIATED	HPSE2 ADAMTS8 SEMA4G LGALS4 TGM1 LOX LOXL1 LOXL2 LPA PCSK6 PLG MMP15 ADAMTSL4 PLXNB3	1.87e-05	738	130	14	MM17058
Coexpression	NABA_MATRISOME_ASSOCIATED	HPSE2 ADAMTS8 SEMA4G LGALS4 TGM1 LOX LOXL1 LOXL2 LPA PCSK6 PLG MMP15 ADAMTSL4 PLXNB3	2.27e-05	751	130	14	M5885
Coexpression	MEK_UP.V1_UP	MAOA PEG10 PPP1R13B PTPRU PTK7 LOXL1 BCAM	5.53e-05	195	130	7	M2725
Coexpression	GSE5589_WT_VS_IL6_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN	MAOA WDR25 H6PD LOX TNRC6A IQSEC1 PLEKHA5	6.29e-05	199	130	7	M6646
Coexpression	GSE11961_MARGINAL_ZONE_BCELL_VS_PLASMA_CELL_DAY7_UP	FAM234B OXCT1 MDN1 SVIL DISP2 DMRTA1 GNL1	6.49e-05	200	130	7	M9322
Coexpression	GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP	FAM234B VPS33A PPP1R13B OXCT1 LOX LOXL2 RAD54L	6.49e-05	200	130	7	M6661
Coexpression	GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP	IL11RA MARCHF6 SLC30A6 MAST4 SVIL IQSEC1 LTBP3	6.49e-05	200	130	7	M9889
ToppCell	390C-Lymphocytic-ILC-ILC-2\|390C / Donor, Lineage, Cell class and subclass (all cells)	VPS33A MARCHF6 CDAN1 CD7 EPS8L3 GNL1 IGKV3-20 SOS1	3.53e-08	168	130	8	2781dd6b369427a94c5059b44b4c8f023f5f2988
ToppCell	(04)_Pre-ciliated-(4)_1wkpi\|(04)_Pre-ciliated / shred by cell type and Timepoint	HIC1 HPSE2 LRRC25 MAMDC2 LRP3 PLG	2.47e-07	89	130	6	846c2fec66981bf41be64a2e1812ec1b1b833961
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Adult / Lineage, Cell type, age group and donor	ST6GALNAC1 PPP1R13B GLCCI1 MAST4 PITPNM3 RP1 DNAH5	5.23e-07	163	130	7	e819a1d6d28290854aa0672b3a18fa9e293d8f23
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	IL11RA ZNF469 COCH LOX LOXL1 MAMDC2 PLG	6.67e-07	169	130	7	031465190cd3623a25ef2b868daab8d932c8ff08
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	IL11RA ZNF469 COCH LOX LOXL1 MAMDC2 PLG	7.22e-07	171	130	7	15cb4670ff4234ac46aea8a5911138d6913c4482
ToppCell	356C-Lymphocytic-CD4_T-cell-Treg_cell_1\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	KLHDC7B HLCS SLCO4A1 SLC30A6 LOXL1 SVIL DTHD1	9.10e-07	177	130	7	36b5d29caa9cffbc0284f771a4db71aa72171a89
ToppCell	droplet-Lung-18m-Mesenchymal-fibroblast\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	IL11RA ADAMTS8 H6PD PTK7 LOX LOXL1 MAMDC2	1.41e-06	189	130	7	e76dc36a01d8ad7590b3acc4c46abfcb76857448
ToppCell	droplet-Lung-21m-Mesenchymal-fibroblast\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	IL11RA HIC1 ADAMTS8 H6PD PTK7 LOXL1 MAMDC2	1.51e-06	191	130	7	8a73d2df079566fca4cbb5cdb85721c2e87134c8
ToppCell	droplet-Lung-nan-18m-Mesenchymal\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL11RA ADAMTS8 H6PD PTK7 LOX LOXL1 MAMDC2	1.57e-06	192	130	7	df56c3e3bb1aafc1126607f4426554c09c8c40cf
ToppCell	facs-Lung-3m-Mesenchymal\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	IL11RA ADAMTS8 H6PD LOX LOXL1 MAMDC2 LOXL2	1.57e-06	192	130	7	8df15085b35b86f39debd933284cb703c5dd63c2
ToppCell	10x3'2.3-week_17-19-Endothelial-stroma-tip_EC\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	HIC1 SHANK3 MAST4 BCAM CTNND1 MAPK11 MMP15	1.86e-06	197	130	7	b212ff28ca2d1fea4140f186ab90941bdca21249
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_only / Treatment groups by lineage, cell group, cell type	IL11RA MAOB HPSE2 OXCT1 SVIL LRP3 LTBP3	2.06e-06	200	130	7	593bf6a7c557437db9a9249a5058a46014179ef6
ToppCell	facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AGO2 HLCS SEMA4G LOXL2 AFF1 DEPDC5	8.49e-06	163	130	6	953a7db7e90a913e81002d2141fbbd5f1fdf2197
ToppCell	390C-Lymphocytic-ILC\|390C / Donor, Lineage, Cell class and subclass (all cells)	MARCHF6 CDAN1 CD7 EPS8L3 IGKV3-20 SOS1	8.79e-06	164	130	6	b0fc63b72162b5cc4d1e0a271a12f3d3ab29398f
ToppCell	normal_Lung-Fibroblasts-Pericytes\|Fibroblasts / Location, Cell class and cell subclass	OBSCN ADARB2 LOXL2 LTK MMP15 RAD54L	1.08e-05	170	130	6	d69c0ea4cb6b204f19d0a5d2164afb42184779ac
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD8-Tem/emra_CD8\|GI_small-bowel / Manually curated celltypes from each tissue	MAOA LGALS4 KCNA1 SCG2 IGKV3-20 IGKV3-7	1.12e-05	171	130	6	f28684ea0e74a22f4c140658496068e28a6d3605
ToppCell	droplet-Spleen-SPLEEN-1m-Hematologic-erythroblast\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAM234B WDR25 AARS2 MMAB SPTY2D1	1.13e-05	100	130	5	f305bc37f97617007b59bf06d288dd14c3c06e42
ToppCell	tumor_Lymph_Node_/_Brain-B_lymphocytes-Undetermined\|B_lymphocytes / Location, Cell class and cell subclass	CDK18 HIC1 CDAN1 CD7 LOXL2 DTHD1	1.23e-05	174	130	6	390bd41ef114464f3db3e0cac4e67fe7571b4c23
ToppCell	3'-Pediatric_IBD-SmallIntestine-Epithelial-goblet-BEST2+_Goblet_cell\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ST6GALNAC1 SLCO4A1 LGALS4 MISP CLCA1 DISP2	1.45e-05	179	130	6	c833ded1f9e87be2ba2037820d92a389560b711c
ToppCell	facs-Lung-nan-3m-Mesenchymal-fibroblast_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAMTS8 H6PD PTK7 LOX LOXL1 MAMDC2	1.59e-05	182	130	6	c557de6ccd327c46e0a5423cd9936d78e0abae5f
ToppCell	facs-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAMTS8 H6PD PTK7 LOX LOXL1 MAMDC2	1.59e-05	182	130	6	dbe4b2557cf19e0682ed446f8397d3a1153642f0
ToppCell	Mild_COVID-19-Epithelial-AT1/AT2\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	MAOA MAOB PTK7 MAMDC2 SCG2 BCAM	1.74e-05	185	130	6	c55fdba1e3818ec0404d7ab473bf18dd25f2bb0a
ToppCell	droplet-Lung-LUNG-30m-Mesenchymal-Alveolar_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAMTS8 H6PD PTK7 LOX LOXL1 MAMDC2	1.80e-05	186	130	6	ca5e9c6531cb5d199e27509bfab1d62e3937177e
ToppCell	droplet-Lung-LUNG-30m-Mesenchymal-fibroblast_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAMTS8 H6PD PTK7 LOX LOXL1 MAMDC2	1.80e-05	186	130	6	1ed71b229f40a680071b14f5a7a19706e0fd14b1
ToppCell	droplet-Lung-18m-Mesenchymal\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	IL11RA ADAMTS8 H6PD PTK7 LOXL1 MAMDC2	2.02e-05	190	130	6	0b7200897b2c389632c9b1ee37e272b811555dbc
ToppCell	droplet-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADAMTS8 H6PD PTK7 LOX LOXL1 MAMDC2	2.09e-05	191	130	6	36467322096bc766cd777dae3bfb4e65511e492c
ToppCell	droplet-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADAMTS8 H6PD PTK7 LOX LOXL1 MAMDC2	2.09e-05	191	130	6	94795daf05061baa3b72a1b01c9e940af86de044
ToppCell	facs-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADAMTS8 H6PD PTK7 LOX LOXL1 MAMDC2	2.09e-05	191	130	6	d4f535b06ad483448ab692e9900c872c78cbed60
ToppCell	droplet-Lung-1m-Mesenchymal-fibroblast-alveolar_fibroblast\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HIC1 ADAMTS8 H6PD PTK7 LOXL1 MAMDC2	2.09e-05	191	130	6	d04e6292fef189b8d8ed0f4b0c310b2b250fd30e
ToppCell	droplet-Lung-1m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HIC1 ADAMTS8 H6PD PTK7 LOXL1 MAMDC2	2.09e-05	191	130	6	de3e9b704621b26836c2ddc39fa3e840dfb4541b
ToppCell	facs-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADAMTS8 H6PD PTK7 LOX LOXL1 MAMDC2	2.09e-05	191	130	6	b5210de890d338602857b5907135705a507bc2b0
ToppCell	droplet-Lung-21m-Mesenchymal\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	IL11RA ADAMTS8 H6PD PTK7 LOXL1 MAMDC2	2.09e-05	191	130	6	10a9db1caa0fdb51ace8537f42b2c66f7c97e0f5
ToppCell	facs-Marrow-T-cells-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HDAC9 GLCCI1 MAST4 IQSEC1 UNC93B1 RUBCN	2.15e-05	192	130	6	2de242d81dc085ae734eb7d1f091af9a542e0866
ToppCell	droplet-Lung-nan-18m-Mesenchymal-Alveolar_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAMTS8 H6PD PTK7 LOX LOXL1 MAMDC2	2.15e-05	192	130	6	d22c1135867bcb9076435e2c6eb1cc1248990d0c
ToppCell	human_hepatoblastoma-Tumor_cells-T8\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	MAOA MAOB LPA PCSK6 PLG MMAB	2.15e-05	192	130	6	e785135262f4c9cc66c403bf362bb34643b212c5
ToppCell	droplet-Lung-nan-18m-Mesenchymal-fibroblast_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAMTS8 H6PD PTK7 LOX LOXL1 MAMDC2	2.15e-05	192	130	6	c09966f4d63a739a56db4df7e0e0ee9ecacd21ad
ToppCell	facs-Marrow-T-cells-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HDAC9 GLCCI1 MAST4 IQSEC1 UNC93B1 RUBCN	2.15e-05	192	130	6	ba2a683472a8b785dbf666dc6e94356d879486c3
ToppCell	droplet-Lung-nan-21m-Mesenchymal\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL11RA HIC1 ADAMTS8 PTK7 LOXL1 MAMDC2	2.15e-05	192	130	6	e429e8fbc48ad26204a0197b9129e58be56bd7b6
ToppCell	facs-Lung-EPCAM-18m-Mesenchymal\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL11RA HIC1 ADAMTS8 H6PD LOXL1 MAMDC2	2.15e-05	192	130	6	5876ff75e273a48e7ad8236423fb41e4ae4c0a91
ToppCell	facs-Lung-EPCAM-18m-Mesenchymal-Alveolar_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAMTS8 H6PD PTK7 LOX LOXL1 MAMDC2	2.21e-05	193	130	6	fa45042d30f9cfeed10e23270a78f18551219cfa
ToppCell	droplet-Limb_Muscle-nan-18m-Mesenchymal\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL11RA H6PD LOX LOXL1 PCSK6 LTBP3	2.21e-05	193	130	6	49600db68ed65cafc67bd45a285b364e4f5f88af
ToppCell	PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ADAMTS8 H6PD PTK7 LOX LOXL1 MAMDC2	2.21e-05	193	130	6	4c74a3f69b2cbdf139e7e66b44bd86869ac34dc0
ToppCell	droplet-Lung-nan-21m-Mesenchymal-Alveolar_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HIC1 ADAMTS8 H6PD PTK7 LOXL1 MAMDC2	2.21e-05	193	130	6	ac4270b26f5dc7ff2220a109e5aae5a113893211
ToppCell	PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ADAMTS8 H6PD PTK7 LOX LOXL1 MAMDC2	2.21e-05	193	130	6	ff8ceeb3cfd1bef7239df490c19d181091750833
ToppCell	droplet-Lung-nan-21m-Mesenchymal-fibroblast_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HIC1 ADAMTS8 H6PD PTK7 LOXL1 MAMDC2	2.21e-05	193	130	6	7a09739d0b07dcd615cce2da93fd169cc92e566d
ToppCell	facs-Lung-EPCAM-18m-Mesenchymal-fibroblast_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAMTS8 H6PD PTK7 LOX LOXL1 MAMDC2	2.21e-05	193	130	6	ab511ea9e09216a965b3ae5a94f8c3c1ae33d944
ToppCell	facs-Marrow-T-cells-3m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HDAC9 GLCCI1 LIG4 AFF1 UNC93B1 RUBCN	2.28e-05	194	130	6	11709704079f24a730476572dc2f01e9d2226e2c
ToppCell	facs-Marrow-T-cells-3m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HDAC9 GLCCI1 LIG4 AFF1 UNC93B1 RUBCN	2.28e-05	194	130	6	3a1f95639d5f239f001bd67d4213e8938e7f299d
ToppCell	15-Trachea-Mesenchymal\|Trachea / Age, Tissue, Lineage and Cell class	IL11RA HIC1 LOX LOXL1 LOXL2 ADAMTSL4	2.41e-05	196	130	6	7e178c76285e61c721c38d7a995ebf89dc428f9f
ToppCell	10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-D\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HIC1 HLCS PPP1R13B CD7 AARS2 SHPRH	2.41e-05	196	130	6	c57a95f8b4d8d6334f269d3c16246684f4222a3e
ToppCell	15-Trachea-Mesenchymal-Mesenchyme_SERPINF1-high\|Trachea / Age, Tissue, Lineage and Cell class	IL11RA HIC1 LOX LOXL1 LOXL2 ADAMTSL4	2.41e-05	196	130	6	54aefcebf13704f51de84379e2e22ec0734b9461
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IL11RA PEG10 KCNA1 LOX SVIL ADAMTSL4	2.48e-05	197	130	6	2744cc94883c5d0424677cf5093bbab622933e9b
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IL11RA PEG10 KCNA1 LOX SVIL ADAMTSL4	2.48e-05	197	130	6	6b6440f1baad5680cf9e13ca3ab72a2c65523d59
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Macroglial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAPK8IP1 FAM234B ARSG KCNA1 PCSK6 PLXNB3	2.55e-05	198	130	6	731a90f7e68b19e387499d63e3979af78b503b0c
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IL11RA PEG10 ZNF469 LOX LOXL1 MAMDC2	2.55e-05	198	130	6	9541d68a1a6247dbd7161a62644eea6527c2c8ff
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAPK8IP1 FAM234B ARSG KCNA1 PCSK6 PLXNB3	2.55e-05	198	130	6	43a2ce64fa309bac89a44ea320e87ae2cc39f782
ToppCell	10x3'2.3-week_17-19-Endothelial\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	HIC1 SHANK3 MAST4 BCAM CTNND1 MMP15	2.55e-05	198	130	6	2630a7a6e56febe5c0b0bde70dd7292fa1650c47
ToppCell	10x3'2.3-week_17-19-Endothelial-stroma\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	HIC1 SHANK3 MAST4 BCAM CTNND1 MMP15	2.55e-05	198	130	6	1e83bec16dcd60460422625f89952ff506d6be51
ToppCell	Parenchymal-10x3prime_v2-Epithelial-Epi_alveolar-Dividing_AT2\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	KIF23 PEG10 SLC30A6 COCH PITPNM3 DNAH5	2.70e-05	200	130	6	befc25cbcbac2c02e5fd33d6e78e59979050090c
ToppCell	BAL-Severe-cDC_6\|Severe / Compartment, Disease Groups and Clusters	KIF23 HLCS LOX MAMDC2 MMAB	4.00e-05	130	130	5	4104d1e10609331b67db3b85c63537aec58b1713
ToppCell	frontal_cortex-Non-neuronal-oligodendrocyte-Oligo-OPC_Pdgfra_Grm5\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	BCAN ZNF469 DMRTA1 MMP15 PLXNB3	4.46e-05	133	130	5	63d2f096ae47d9b587acc6c5fbd346e5e58842b8
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HIC1 EARS2 HDHD5 CD7 DTHD1	9.21e-05	155	130	5	c58a5fb8d853f12204e961d633e83452eb12a659
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HIC1 EARS2 HDHD5 CD7 DTHD1	9.21e-05	155	130	5	9cb8c42c2e451b2d4dcd7154a4b1bfd21bbb7ea8
ToppCell	BAL-Severe-Myeloid-cDC-cDC-cDC_6\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HLCS LOX MAMDC2 PLEKHA5 MMAB	9.49e-05	156	130	5	0f2147abcf31a26ee5b2f4d8c5d72232612a33f0
ToppCell	BAL-Severe-Myeloid-cDC-cDC-cDC_6\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLCS LOX MAMDC2 PLEKHA5 MMAB	9.49e-05	156	130	5	cb87f12443fdc5538b856f765fcbac9406044e10
ToppCell	Control-Epithelial_alveolar-AT_2-Differentiating_AT1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SLCO4A1 PTPRU LIG4 SCAP PLEKHA7	9.78e-05	157	130	5	4766f7d545bf2d775390589460677519cb92f4d5
ToppCell	facs-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l7\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SHANK3 RP1 BCAM PLG MMP15	1.01e-04	158	130	5	78b48b110b777bcc4c07cd23388bee911c0231d6
ToppCell	PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_prolif\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KIF23 B4GALNT1 GPR25 WDR18 CD7	1.04e-04	159	130	5	e9c51e611ebd427bbe51e3e036c14122c36ea372
ToppCell	PBMC-Mild-Myeloid-cDC-cDC-cDC_6\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HIC1 WDR18 ZNF469 TRMT6 PITPNM3	1.04e-04	159	130	5	6115cb03c2ad08e4c1b65893d522f685ff0bc692
ToppCell	PBMC-Mild-Myeloid-cDC-cDC-cDC_6\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HIC1 WDR18 ZNF469 TRMT6 PITPNM3	1.07e-04	160	130	5	a90eb621481fd07a821495db07d1032e109fd386
ToppCell	Fetal_29-31_weeks-Epithelial-club_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MAOA PPP1R13B MAST4 RP1 DNAH5	1.13e-04	162	130	5	5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81
ToppCell	facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HLCS SEMA4G LOXL2 AFF1 SOS1	1.17e-04	163	130	5	132aece9c79499b4bb3c2bde68d3d7202e1d8772
ToppCell	Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3\|Striatum / BrainAtlas - Mouse McCarroll V32	ADAMTS8 METTL24 LOX MAMDC2 BCAM	1.20e-04	164	130	5	e24b06a14565f7798ac50c2fe3f34d4547b9000e
ToppCell	Mild-MAIT\|World / Disease group and Cell class	HDAC9 HIC1 LRFN1 RP1 LTK	1.20e-04	164	130	5	21dc02997dfae73cf70ce291661928526605dba1
ToppCell	facs-Marrow-T-cells-3m-Lymphocytic-Klrb1a/b/c(-)_NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HIC1 MISP CD7 DMRTA1 ADAMTSL4	1.23e-04	165	130	5	651d40eadb1b34de618af94c167f43635729d43f
ToppCell	356C-Epithelial_cells-Epithelial-D_(AT2)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	PEG10 PTPRU MISP BCAM MMP15	1.27e-04	166	130	5	2e4cb4056e6b0c43290a5588ff525f5f05b8beee
ToppCell	356C-Epithelial_cells-Epithelial-D_(AT2)\|356C / Donor, Lineage, Cell class and subclass (all cells)	PEG10 PTPRU MISP BCAM MMP15	1.27e-04	166	130	5	eb8d972326a734549675307e411fc795af66da70
ToppCell	facs-Lung-EPCAM-24m-Myeloid-Plasmacytoid_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAM234B SLCO4A1 LGALS4 LIG4 CD7	1.31e-04	167	130	5	e0f2509e86302eca8352821bce12597f6c51fc24
ToppCell	facs-Lung-EPCAM-24m-Myeloid-plasmacytoid_dendritic_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAM234B SLCO4A1 LGALS4 LIG4 CD7	1.31e-04	167	130	5	b25646b6653cd8814dbeae4c74ce899ede105200
ToppCell	facs-Aorta-Heart-24m-Endothelial-endocardial_endothelial_cells\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADARB2 COCH CLCA1 PLEKHA7 RUBCN	1.34e-04	168	130	5	edbab94f14e16a1a76546a18fe777a183080d1de
ToppCell	droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	OBSCN H6PD METTL24 LOXL1 MAMDC2	1.34e-04	168	130	5	d2b91f2adc95dcfa623f8d7ca2df1c6f884da988
ToppCell	343B-Myeloid-Dendritic-pDC\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	HLCS PCSK6 LTK RUBCN LILRA4	1.38e-04	169	130	5	632aa3ab39ec87bafcefec6cddf71129a054d3b0
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Epithelial-goblet-Goblet_cell\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ST6GALNAC1 LGALS4 KCNH6 CLCA1 DISP2	1.42e-04	170	130	5	2c5a1469e5743870e96e6c2cc92f0c5096b79f51
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Epithelial-goblet\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ST6GALNAC1 LGALS4 KCNH6 CLCA1 DISP2	1.42e-04	170	130	5	9bea81031cdfe45e8cddac3a3afd9ca6c331c45a
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	OBSCN SLCO4A1 QRICH2 SHANK3 LIG4	1.46e-04	171	130	5	1ae4b6a25bc9c1065cf5d95998ebcc70aee21ab5
ToppCell	390C-Lymphocytic-ILC\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	MARCHF6 CDAN1 PLEKHA5 EPS8L3 IGKV3-20	1.46e-04	171	130	5	70963f79711fe6088d6d01b29206b17ab89e5e73
ToppCell	343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	LRFN1 BICRA DISP2 TRAK2 LTK	1.50e-04	172	130	5	d65ffff3e341af34a043a0d802d7ba4b69de36e9
ToppCell	Healthy/Control-Plasmablast\|World / Disease group and Cell class	GPR25 SLCO4A1 FBXO10 LTK PLEKHA7	1.50e-04	172	130	5	d3bfcf5d936152b71cd90f955f9331709edd979e
ToppCell	367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	QRICH2 TASOR2 CDAN1 LOX PCSK6	1.50e-04	172	130	5	da959c1abadafd79b7a0088a25eb8ef8efa3a0c2
ToppCell	390C-Lymphocytic-ILC-ILC-2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	MARCHF6 CDAN1 EPS8L3 IGKV3-20 SOS1	1.50e-04	172	130	5	84d16cd7f618c94888920680bdc9e7130d73fd75
ToppCell	5'-Adult-Appendix-Mesenchymal-myocytic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HPSE2 MAMDC2 SVIL PLEKHA5 PLXNB3	1.54e-04	173	130	5	f8e3dded726bb3a6c24bfedf8c6732bb46262308
ToppCell	facs-Lung-Endomucin-24m-Myeloid-Myeloid_Dendritic_Type_1\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF23 MCPH1 TRMT6 CD7 REEP4	1.58e-04	174	130	5	7565f6d1c743809807d248ab0e098a2474d9c5b9
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	OBSCN HPSE2 MAMDC2 LOXL2 PLEKHA5	1.58e-04	174	130	5	f90ca117b729436cf452e2ddcec26ba525c5c13b
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-Myeloid_Dendritic_Type_1\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF23 HLCS LGALS4 OXCT1 CD7	1.58e-04	174	130	5	ff13a5c55d18b951315908f33cb47c7f9cb901bf
ToppCell	3'-GW_trimst-1-SmallIntestine-Epithelial-mature_enterocytic-Paneth\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ST6GALNAC1 SLCO4A1 LGALS4 KCNH6 CLCA1	1.58e-04	174	130	5	b4483d7d9f22f09ed7fa0b72305434a47ccaade0
ToppCell	343B-Myeloid-Dendritic-pDC\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	HLCS PCSK6 IQSEC1 LTK LILRA4	1.63e-04	175	130	5	b30589ff9dc18e745afe61f289e6d576c9c6c6b2
ToppCell	CV-Mild-6\|Mild / Virus stimulation, Condition and Cluster	BCAN DEPDC5 CTNND1 ZNF839 ZNF415	1.63e-04	175	130	5	c4d530dbb37942427c9cd0a1533faeb6a3a45381
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-late_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLCO4A1 PTK7 KCNH6 TGM1 RAD54L	1.67e-04	176	130	5	3766e0533b103ec92ac75eba3df02e287efc53fa
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Epithelial-epithelial_progenitor_cell-TA\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MAOA SEMA4G LGALS4 EPS8L3 BCAM	1.67e-04	176	130	5	e7502a345b2da83a9a60f50cf78f1aef385c99df
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-late_pro_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLCO4A1 PTK7 KCNH6 TGM1 RAD54L	1.67e-04	176	130	5	aa1bada2175d8370fc71939a607407155259d195
Drug	pyrazidol	MAOA MAOB LOXL1 LOXL2 BCAM	2.98e-10	8	129	5	CID000068802
Drug	BU 224	MAOA MAOB LOXL1 LOXL2	3.40e-08	7	129	4	CID000002457
Drug	N-(2-aminoethyl)benzamide	MAOA MAOB LOXL1 LOXL2	3.40e-08	7	129	4	CID000423156
Drug	cimoxatone	MAOA MAOB LOXL1 LOXL2	3.40e-08	7	129	4	CID000052542
Drug	JB 835	MAOA MAOB LOXL1 LOXL2	3.40e-08	7	129	4	CID000152988
Drug	1-benzylcyclopropylamine	MAOA MAOB LOXL1 LOXL2	3.40e-08	7	129	4	CID000152923
Drug	MPTP-3-ol	MAOA MAOB LOXL1 LOXL2	3.40e-08	7	129	4	CID000100194
Drug	iproclozide	MAOA MAOB LOXL1 LOXL2	3.40e-08	7	129	4	CID000019063
Drug	4-methoxytranylcypromine	MAOA MAOB LOXL1 LOXL2	3.40e-08	7	129	4	CID003082143
Drug	SR 95191	MAOA MAOB LOXL1 LOXL2	3.40e-08	7	129	4	CID000072119
Drug	AC1O5VTH	MAOA MAOB LOXL1 LOXL2	6.76e-08	8	129	4	CID006441710
Drug	mofegiline	MAOA MAOB LOXL1 LOXL2	6.76e-08	8	129	4	CID006437850
Drug	4-fluorotranylcypromine	MAOA MAOB LOXL1 LOXL2	6.76e-08	8	129	4	CID003082666
Drug	3-amino-2-oxazolidinone	MAOA MAOB LOXL1 LOXL2	1.21e-07	9	129	4	CID000065725
Drug	MDL 72392	MAOA MAOB LOXL1 LOXL2	1.21e-07	9	129	4	CID006439254
Drug	AC1L1BMC	MAOA MAOB LOXL1 LOXL2	1.21e-07	9	129	4	CID000001500
Drug	FLA 336	MAOA MAOB LOXL1 LOXL2	1.21e-07	9	129	4	CID000123706
Drug	Ro 16-6491	MAOA MAOB LOXL1 LOXL2	1.21e-07	9	129	4	CID000004289
Drug	toloxatone	MAOA MAOB LOXL1 LOXL2	1.21e-07	9	129	4	CID000034521
Drug	RS-8359	MAOA MAOB LOXL1 LOXL2	1.21e-07	9	129	4	CID000164116
Drug	esuprone	MAOA MAOB BCAM	1.78e-07	3	129	3	CID000065827
Drug	NSC-169892	MAOA MAOB LOXL1 LOXL2	2.01e-07	10	129	4	CID000043479
Drug	acetylcadaverine	MAOA MAOB LOXL1 LOXL2	2.01e-07	10	129	4	CID000189087
Drug	3-dimethylamino-1-propyne	MAOA MAOB LOXL1 LOXL2	2.01e-07	10	129	4	CID000081643
Drug	N-cyclopropylbenzylamine	MAOA MAOB LOXL1 LOXL2	2.01e-07	10	129	4	CID000025866
Drug	acetylputrescine	HDAC9 MAOA MAOB LOXL1 LOXL2	2.11e-07	24	129	5	CID000122356
Drug	befloxatone	MAOA MAOB LOXL1 LOXL2	3.15e-07	11	129	4	CID000060824
Drug	chlorphentermine	MAOA MAOB LOXL1 LOXL2 PLCB3	3.23e-07	26	129	5	CID000010007
Drug	semicarbazide	MAOA MAOB LOX LOXL1 LOXL2 SOS1	4.30e-07	51	129	6	CID000005196
Drug	2-(2-benzofuranyl)-2-imidazoline	MAOA MAOB LOXL1 LOXL2	4.70e-07	12	129	4	CID003080926
Drug	tylciprine	MAOA MAOB LOXL1 LOXL2	4.70e-07	12	129	4	CID000026069
Drug	pheniprazine	MAOA MAOB LOXL1 LOXL2	4.70e-07	12	129	4	CID000005929
Drug	viloxazine	MAOA MAOB LOXL1 LOXL2	4.70e-07	12	129	4	CID000005666
Drug	FNPA	MAOA MAOB LOXL1 LOXL2	4.70e-07	12	129	4	CID000093121
Drug	HLA20	MAOA MAOB LOXL1 LOXL2	4.70e-07	12	129	4	CID006918819
Drug	lithium carbonate	MAOA MAOB TGM1 LOXL1 LOXL2	4.78e-07	28	129	5	CID000011125
Drug	benzylamine	MAOA MAOB KCNA1 LOX LOXL1 LOXL2	4.84e-07	52	129	6	CID000007504
Drug	pentylamine	MAOA MAOB TGM1 LOXL1 LOXL2 DMRTA1	5.43e-07	53	129	6	CID000008060
Drug	isocarboxazid	MAOA MAOB LOXL1 LOXL2	9.42e-07	14	129	4	CID000003759
Drug	FMMT	MAOA MAOB LOXL1 LOXL2	9.42e-07	14	129	4	CID006438682
Drug	MDL 72145	MAOA MAOB LOXL1 LOXL2	9.42e-07	14	129	4	CID006438383
Drug	2'CH3-MPTP	MAOA MAOB LOXL1 LOXL2	9.42e-07	14	129	4	CID000091767
Drug	kynuramine	MAOA MAOB LOXL1 LOXL2	9.42e-07	14	129	4	CID000009692
Drug	lazabemide	MAOA MAOB LOXL1 LOXL2	9.42e-07	14	129	4	CID000071307
Drug	MFMD	MAOA MAOB LOXL1 LOXL2	1.28e-06	15	129	4	CID000122302
Drug	Ro 41-1049	MAOA MAOB LOXL1 LOXL2	1.70e-06	16	129	4	CID000005086
Drug	allylamine	MAOA MAOB LOX LOXL1 LOXL2	1.77e-06	36	129	5	CID000007853
Drug	5-methyltryptamine	MAOA MAOB LOXL1 LOXL2	2.21e-06	17	129	4	CID000015760
Drug	N-desisopropylpropranolol	MAOA MAOB LOXL1 LOXL2	2.21e-06	17	129	4	CID000159899
Drug	NSC142627	MAOA MAOB LOXL1 LOXL2	2.21e-06	17	129	4	CID000422254
Drug	alpha-methyltryptamine	MAOA MAOB LOXL1 LOXL2	2.21e-06	17	129	4	CID000009287
Drug	protriptyline	MAOA MAOB LOXL1 LOXL2	2.83e-06	18	129	4	CID000004976
Drug	5-methoxyindole-3-acetic acid	MAOA MAOB LOXL1 LOXL2	2.83e-06	18	129	4	CID000018986
Drug	T 794	MAOA LOXL1 LOXL2	3.51e-06	6	129	3	CID003077680
Drug	NSD 2023	MAOA LOXL1 LOXL2	3.51e-06	6	129	3	CID000019831
Drug	1-benzyl-2-methyl-5-methoxytryptamine	MAOA LOXL1 LOXL2	3.51e-06	6	129	3	CID000009925
Drug	BU99006	MAOA LOXL1 LOXL2	3.51e-06	6	129	3	CID006603748
Drug	5-hydroxyisatin	MAOA LOXL1 LOXL2	3.51e-06	6	129	3	CID010352011
Drug	1-PCPA	MAOA LOXL1 LOXL2	3.51e-06	6	129	3	CID000194548
Drug	N-cyclopropyl-5,6-dimethoxytryptamine	MAOA LOXL1 LOXL2	3.51e-06	6	129	3	CID000156277
Drug	N-cyclopropyl-6,7-dimethoxytryptamine	MAOA LOXL1 LOXL2	3.51e-06	6	129	3	CID000156278
Drug	N-cyclopropyl-alpha-methylbenzylamine	MAOA LOXL1 LOXL2	3.51e-06	6	129	3	CID000362778
Drug	p-methoxyamphetamine	MAOA MAOB LOXL1 LOXL2	3.57e-06	19	129	4	CID000031721
Drug	norfenefrine	MAOA MAOB LOXL1 LOXL2	3.57e-06	19	129	4	CID000004538
Drug	3-hydroxybenzyl	MAOA MAOB LOXL1 LOXL2	3.57e-06	19	129	4	CID000145655
Drug	m-tyramine	MAOA MAOB LOXL1 LOXL2	3.57e-06	19	129	4	CID000011492
Drug	nefazodone	MAOA MAOB LOXL1 LOXL2 DMRTA1	4.37e-06	43	129	5	CID000004449
Drug	alpha-Te	MAOA MAOB LOXL1 LOXL2	4.44e-06	20	129	4	CID000023353
Drug	3,4-dihydroxymandelic acid	MAOA MAOB LOXL1 LOXL2	4.44e-06	20	129	4	CID000085782
Drug	AC1LAD18	MAOA MCPH1 MAOB LOXL1 LOXL2	4.91e-06	44	129	5	CID000466138
Drug	hydroxyamphetamine	MAOA MAOB LOXL1 LOXL2	5.46e-06	21	129	4	CID000003651
Drug	iproniazid	MAOA MAOB LOXL1 LOXL2	5.46e-06	21	129	4	CID000003748
Drug	AC1MI4WR	MAOA MAOB LOXL1 LOXL2	5.46e-06	21	129	4	CID003038476
Drug	nialamide	MAOA MAOB LOXL1 LOXL2	5.46e-06	21	129	4	CID000004472
Drug	1,2,3-triazole	MAOA MAOB LOXL1 LOXL2 DNAH5	5.50e-06	45	129	5	CID000067516
Drug	dimethylphenethylamine	MAOA LOXL1 LOXL2	6.12e-06	7	129	3	CID000025124
Drug	tetrahydroharmine	MAOA LOXL1 LOXL2	6.12e-06	7	129	3	CID000159809
Drug	4'-amino-MPTP	MAOA LOXL1 LOXL2	6.12e-06	7	129	3	CID000086263
Drug	M 2113	MAOA LOXL1 LOXL2	6.12e-06	7	129	3	CID000072895
Drug	brofaromine	MAOA LOXL1 LOXL2	6.12e-06	7	129	3	CID000044570
Drug	1-Phenylcyclobutylamine	MAOA LOXL1 LOXL2	6.12e-06	7	129	3	CID000152214
Drug	RS-2232	MAOA LOXL1 LOXL2	6.12e-06	7	129	3	CID000134882
Drug	isoniazid	MAOA MCPH1 MAOB TGM1 LOX LOXL1 LOXL2	6.55e-06	123	129	7	CID000003767
Drug	coprine	MAOA MAOB LOXL1 LOXL2	6.65e-06	22	129	4	CID000108079
Drug	amitraz	MAOA MAOB LOXL1 LOXL2	6.65e-06	22	129	4	CID000036324
Drug	5-methoxytryptophol	MAOA MAOB LOXL1 LOXL2	6.65e-06	22	129	4	CID000012835
Drug	5-hydroxyindole	MAOA MAOB LIG4 LOXL1 LOXL2	9.33e-06	50	129	5	CID000016054
Drug	AC1Q6B1A	MAOA LOXL1 LOXL2	9.75e-06	8	129	3	CID000088562
Drug	Q 192	LOX LOXL1 LOXL2	9.75e-06	8	129	3	CID000077317
Drug	4-chlorobenzylamine	MAOB LOXL1 LOXL2	9.75e-06	8	129	3	CID000066036
Drug	amezinium	MAOA LOXL1 LOXL2	9.75e-06	8	129	3	CID000071926
Drug	mebanazine	MAOA LOXL1 LOXL2	9.75e-06	8	129	3	CID000006179
Drug	ranbezolid	MAOA LOXL1 LOXL2	9.75e-06	8	129	3	CID000496993
Drug	2-propyl-pentylamine	MAOA LOXL1 LOXL2	9.75e-06	8	129	3	CID000170419
Drug	isatin	MAOA MAOB PTK7 LOXL1 LOXL2	1.03e-05	51	129	5	CID000007054
Drug	oxazolidinone	MAOA MAOB LOXL1 LOXL2	1.13e-05	25	129	4	CID000006257
Drug	thallium	MAOA MAOB LOXL1 LOXL2	1.13e-05	25	129	4	CID000105005
Drug	EDTA	MAOA MAOB LOX LOXL1 LOXL2 AFF1 PLG	1.21e-05	135	129	7	CID000006049
Drug	OR-486	MAOA MAOB LOXL1 LOXL2	1.33e-05	26	129	4	CID001810907
Drug	H3-32	MAOA MAOB LOXL1 LOXL2	1.33e-05	26	129	4	CID000082553
Disease	cholesterol to total lipids in small HDL percentage	LPA PCSK6 AFF1 BCAM PLG	2.63e-06	51	126	5	EFO_0022240
Disease	triglycerides to total lipids in small LDL percentage	LPA AFF1 PLCB3 BCAM PLG	5.46e-06	59	126	5	EFO_0022337
Disease	microcephaly (implicated_via_orthology)	MCPH1 DHX37 AARS2 MAPKBP1	1.04e-05	32	126	4	DOID:10907 (implicated_via_orthology)
Disease	cholesteryl esters to total lipids in medium LDL percentage	LPA AFF1 BCAM PLG	1.88e-05	37	126	4	EFO_0022252
Disease	cholesteryl esters to total lipids in small HDL percentage	LPA PCSK6 AFF1 BCAM	3.44e-05	43	126	4	EFO_0022254
Disease	triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement	LPA PCSK6 AFF1 PLCB3 BCAM PLG	4.66e-05	150	126	6	EFO_0004611, EFO_0020947
Disease	free cholesterol to total lipids in small LDL percentage	LPA AFF1 BCAM PLG	7.89e-05	53	126	4	EFO_0022286
Disease	cholesterol to total lipids in large LDL percentage	LPA AFF1 BCAM PLG	9.80e-05	56	126	4	EFO_0022235
Disease	Congenital dyserythropoietic anemia, type III	KIF23 CDAN1	1.79e-04	5	126	2	C0271934
Disease	plasma plasminogen measurement	LPA PLG	1.79e-04	5	126	2	EFO_0006309
Disease	chronic kidney disease, APOL1 risk genotype carrier status	LPA PLG	1.79e-04	5	126	2	EFO_0003884, EFO_0009324
Disease	coronary atherosclerosis measurement	HDAC9 LPA	1.79e-04	5	126	2	EFO_0007938
Disease	triglycerides to phosphoglycerides ratio	LPA AFF1 PLCB3 PLG	2.09e-04	68	126	4	EFO_0022327
Disease	low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	LPA PCSK6 AFF1 PLCB3 BCAM PLG	2.26e-04	200	126	6	EFO_0004611, EFO_0020945
Disease	metabolic syndrome	LPA TNRC6A AFF1 DMRTA1 BCAM PLG	2.26e-04	200	126	6	EFO_0000195
Disease	triglycerides to total lipids in small HDL percentage	LPA AFF1 PLCB3 PLG	2.61e-04	72	126	4	EFO_0022336
Disease	Congenital dyserythropoietic anemia	KIF23 CDAN1	2.68e-04	6	126	2	cv:C0002876
Disease	angiostatin measurement	LPA PLG	2.68e-04	6	126	2	EFO_0008024
Disease	lipoprotein A measurement, apolipoprotein A 1 measurement	LPA PLG	3.75e-04	7	126	2	EFO_0004614, EFO_0006925
Disease	cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement	LPA AFF1 PLCB3 BCAM PLG	3.93e-04	144	126	5	EFO_0004611, EFO_0020943
Disease	triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement	LPA PCSK6 AFF1 PLCB3 BCAM PLG	4.23e-04	225	126	6	EFO_0008317, EFO_0020947
Disease	descending aortic diameter	HDAC9 LOXL1 SVIL DISP2	5.60e-04	88	126	4	EFO_0021788
Disease	cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement	LPA PCSK6 AFF1 PLCB3 BCAM PLG	6.34e-04	243	126	6	EFO_0004612, EFO_0020944
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement, lipid measurement	LPA AFF1 PLCB3 PLG	7.48e-04	95	126	4	EFO_0004529, EFO_0008317, EFO_0008596
Disease	chylomicron measurement, triglyceride measurement, very low density lipoprotein cholesterol measurement	LPA PCSK6 PLCB3 PLG	7.77e-04	96	126	4	EFO_0004530, EFO_0008317, EFO_0008596
Disease	low density lipoprotein cholesterol measurement, alcohol consumption measurement	LPA RP1 PLG SPTY2D1	8.72e-04	99	126	4	EFO_0004611, EFO_0007878
Disease	sexual dimorphism measurement	VPS33A PEX1 SETDB1 KHDRBS1 LOXL1 LOXL2 LPA PKD1 TNRC6A PLCB3 LTBP3 MAPKBP1 LCOR	9.17e-04	1106	126	13	EFO_0021796
Disease	eye measurement, sun exposure measurement	HDAC9 SPAG9	9.70e-04	11	126	2	EFO_0004731, EFO_0010729
Disease	low density lipoprotein cholesterol measurement, alcohol drinking	LPA RP1 PLG SPTY2D1	9.75e-04	102	126	4	EFO_0004329, EFO_0004611
Disease	response to hydrochlorothiazide, fasting blood glucose measurement	AGO2 ADARB2 LOX	1.01e-03	46	126	3	EFO_0004465, EFO_0005202
Disease	cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement	LPA AFF1 PLCB3 BCAM	1.01e-03	103	126	4	EFO_0008595, EFO_0020944
Disease	Fibrosis, Liver	LOX LOXL1 UNC93B1 DNASE2	1.09e-03	105	126	4	C0239946
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement	LPA AFF1 PLCB3 PLG	1.13e-03	106	126	4	EFO_0008317, EFO_0008596
Disease	Amelogenesis Imperfecta	PEX1 LTBP3	1.16e-03	12	126	2	C0002452
Disease	Huntington Disease, Late Onset	MAOA MAOB	1.16e-03	12	126	2	C0393574
Disease	Akinetic-Rigid Variant of Huntington Disease	MAOA MAOB	1.16e-03	12	126	2	C0751207
Disease	Juvenile Huntington Disease	MAOA MAOB	1.16e-03	12	126	2	C0751208
Disease	triglyceride measurement, high density lipoprotein cholesterol measurement	LPA PCSK6 AFF1 PLCB3 BCAM PLG	1.18e-03	274	126	6	EFO_0004530, EFO_0004612
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipid measurement	LPA AFF1 PLCB3 PLG	1.25e-03	109	126	4	EFO_0004639, EFO_0008317, EFO_0008596
Disease	cholesteryl ester measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement	LPA AFF1 PLCB3 PLG	1.29e-03	110	126	4	EFO_0008317, EFO_0008596, EFO_0010351
Disease	free cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement	LPA AFF1 PLCB3 PLG	1.29e-03	110	126	4	EFO_0008317, EFO_0008591, EFO_0008596
Disease	chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement	LPA AFF1 PLCB3 PLG	1.29e-03	110	126	4	EFO_0004574, EFO_0008317, EFO_0008596
Disease	polyunsaturated fatty acids to monounsaturated fatty acids ratio	LPA AFF1 PLG	1.36e-03	51	126	3	EFO_0022302
Disease	cholesterol to total lipids in small VLDL percentage	LPA PCSK6 BCAM	1.36e-03	51	126	3	EFO_0022242
Disease	Fulminant Hepatic Failure with Cerebral Edema	MAOA MAOB	1.37e-03	13	126	2	C0751197
Disease	Hepatic Stupor	MAOA MAOB	1.37e-03	13	126	2	C0751198
Disease	Hepatic Encephalopathy	MAOA MAOB	1.37e-03	13	126	2	C0019151
Disease	Hepatic Coma	MAOA MAOB	1.37e-03	13	126	2	C0019147
Disease	Connective Tissue Diseases	ZNF469 PKD1	1.37e-03	13	126	2	C0009782
Disease	lipoprotein A measurement	LPA AFF1 BCAM PLG	1.38e-03	112	126	4	EFO_0006925
Disease	factor VIII measurement, coronary artery disease	HDAC9 LPA RP1 MMAB	1.43e-03	113	126	4	EFO_0001645, EFO_0004630
Disease	monokine induced by gamma interferon measurement	LIG4 LPA PLG	1.44e-03	52	126	3	EFO_0008236
Disease	triglycerides in HDL measurement	LPA AFF1 PLG	1.52e-03	53	126	3	EFO_0022317
Disease	omega-6 polyunsaturated fatty acid measurement	CDK18 AGO2 LPA AFF1 PLG	1.60e-03	197	126	5	EFO_0005680
Disease	triglycerides in medium HDL measurement	LPA AFF1 PLG	1.61e-03	54	126	3	EFO_0022321
Disease	triglycerides in LDL measurement	LPA AFF1 PLG	1.79e-03	56	126	3	EFO_0022320
Disease	triglycerides to total lipids in medium HDL percentage	LPA AFF1 PLG	1.79e-03	56	126	3	EFO_0022333
Disease	free cholesterol to total lipids in large HDL percentage	LPA BCAM PLG	1.79e-03	56	126	3	EFO_0022279
Disease	cholesteryl esters to total lipids in medium HDL percentage	LPA AFF1 PLG	1.79e-03	56	126	3	EFO_0022251
Disease	Hepatitis C	LOX LOXL2	1.83e-03	15	126	2	C0019196
Disease	cholesterol:total lipids ratio, intermediate density lipoprotein measurement	LPA AFF1 PLCB3 BCAM	1.83e-03	121	126	4	EFO_0008595, EFO_0020943
Disease	triglycerides to total lipids in small VLDL percentage	LPA PCSK6 BCAM	1.98e-03	58	126	3	EFO_0022338
Disease	angina pectoris	HDAC9 LOXL1 LPA PLG	2.06e-03	125	126	4	EFO_0003913
Disease	cholesteryl esters to total lipids in large HDL percentage	LPA AFF1 PLCB3	2.08e-03	59	126	3	EFO_0022248
Disease	interferon gamma measurement, platelet-derived growth factor BB measurement, interleukin 4 measurement, interleukin 10 measurement, stromal cell-derived factor 1 alpha measurement, interleukin-6 measurement, interleukin 12 measurement, interleukin 17 measurement, vascular endothelial growth factor measurement, fibroblast growth factor basic measurement, granulocyte colony-stimulating factor measurement	SCG2 PCSK6	2.09e-03	16	126	2	EFO_0004750, EFO_0004753, EFO_0004762, EFO_0004810, EFO_0008130, EFO_0008142, EFO_0008165, EFO_0008174, EFO_0008184, EFO_0008264, EFO_0008293
Disease	Pheochromocytoma, Extra-Adrenal	MAOA MAOB	2.09e-03	16	126	2	C1257877
Disease	neuroimaging measurement	HDAC9 MCPH1 BCAN GLCCI1 PTK7 ZNF469 MAST4 PKD1 TNRC6A AFF1 DMRTA1 PLEKHA7	2.12e-03	1069	126	12	EFO_0004346
Disease	triglycerides to total lipids in large HDL percentage	LPA AFF1 PLG	2.18e-03	60	126	3	EFO_0022330
Disease	cholesterol to total lipids in medium HDL percentage	LPA AFF1 PLG	2.18e-03	60	126	3	EFO_0022237
Disease	triglycerides:total lipids ratio, intermediate density lipoprotein measurement	LPA AFF1 PLCB3 BCAM	2.19e-03	127	126	4	EFO_0008595, EFO_0020947
Disease	triglycerides in small VLDL measurement	LPA AFF1 PLG	2.28e-03	61	126	3	EFO_0022145
Disease	free cholesterol in IDL measurement	LPA BCAM PLG	2.28e-03	61	126	3	EFO_0022181
Disease	free cholesterol in VLDL measurement	LPA AFF1 BCAM	2.28e-03	61	126	3	EFO_0022276
Disease	Huntington Disease	MAOA MAOB	2.36e-03	17	126	2	C0020179
Disease	free cholesterol measurement, high density lipoprotein cholesterol measurement	LPA PLCB3 BCAM PLG MAPKBP1 MMAB	2.38e-03	315	126	6	EFO_0004612, EFO_0008591
Disease	triglycerides in small HDL measurement	LPA AFF1 PLG	2.39e-03	62	126	3	EFO_0022158
Disease	phospholipids in large VLDL measurement	LPA AFF1 PLG	2.39e-03	62	126	3	EFO_0022169
Disease	triglycerides in medium LDL measurement	LPA AFF1 PLG	2.39e-03	62	126	3	EFO_0022322
Disease	triglycerides to total lipids in very large HDL percentage	LPA AFF1 PLG	2.39e-03	62	126	3	EFO_0022339
Disease	free cholesterol in very large HDL measurement	LPA BCAM PLG	2.39e-03	62	126	3	EFO_0022273
Disease	triglycerides to total lipids in medium VLDL percentage	LPA BCAM PLG	2.50e-03	63	126	3	EFO_0022335
Disease	free cholesterol to total lipids in medium LDL percentage	LPA AFF1 PLG	2.50e-03	63	126	3	EFO_0022283
Disease	phospholipid measurement, high density lipoprotein cholesterol measurement	LPA PCSK6 PLCB3 BCAM PLG MMAB	2.62e-03	321	126	6	EFO_0004612, EFO_0004639
Disease	migraine disorder, systolic blood pressure	HIC1 HPSE2	2.65e-03	18	126	2	EFO_0006335, MONDO_0005277
Disease	very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	LPA PCSK6 PLCB3 BCAM PLG	2.69e-03	222	126	5	EFO_0008317, EFO_0020943
Disease	triglycerides in small LDL measurement	LPA AFF1 PLG	2.74e-03	65	126	3	EFO_0022323
Disease	cortical thickness	HDAC9 B4GALNT1 MCPH1 ADAMTS8 ZNF469 COCH MAST4 PKD1 TNRC6A AFF1 DMRTA1 PLEKHA7	2.95e-03	1113	126	12	EFO_0004840
Disease	cortical surface area change measurement, age at assessment	SPAG9 PCSK6	2.95e-03	19	126	2	EFO_0008007, EFO_0021503
Disease	cerebral infarction (is_marker_for)	LPA SOS1	2.95e-03	19	126	2	DOID:3526 (is_marker_for)
Disease	Pheochromocytoma	MAOA MAOB	2.95e-03	19	126	2	C0031511
Disease	phospholipids:total lipids ratio	LPA PCSK6 AFF1 BCAM PLG	2.96e-03	227	126	5	EFO_0020946
Disease	cholesterol to total lipids in very small VLDL percentage	LPA BCAM PLG	2.98e-03	67	126	3	EFO_0022245
Disease	free cholesterol in large VLDL measurement	LPA AFF1 PLG	3.11e-03	68	126	3	EFO_0022265
Disease	triglycerides to total lipids in very small VLDL percentage	LPA BCAM PLG	3.24e-03	69	126	3	EFO_0022341
Disease	corneal hysteresis	ADAMTS8 ZNF469	3.27e-03	20	126	2	EFO_0010066
Disease	Osteoarthritis of hip	HDAC9 LTBP3	3.27e-03	20	126	2	C0029410
Disease	Deep Vein Thrombosis	LPA PLG	3.60e-03	21	126	2	C0149871
Disease	Venous Thrombosis	LPA PLG	3.60e-03	21	126	2	C0042487
Disease	triglyceride measurement, phospholipid measurement	LPA AFF1 PLCB3 PLG	3.61e-03	146	126	4	EFO_0004530, EFO_0004639
Disease	very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	LPA PCSK6 PLCB3 BCAM PLG	3.69e-03	239	126	5	EFO_0008317, EFO_0020945

Protein segments in the cluster

Peptide	Gene	Start	Entry
RYGQRAQLSGQPDPV	ACCSL	106	Q4AC99
SGGLRGIYLRQLGPQ	CD7	51	P09564
LPLYRTQSRGRGGPL	ADAMTSL4	111	Q6UY14
YRQLLSVEPGAPGLG	B4GALNT1	396	Q00973
KDPGYRGLAFQQPGR	CDK18	451	Q07002
PEPQNGGRYCLGRRA	ADAMTS8	556	Q9UP79
YPLNGILGGSRQPSS	BAZ2A	121	Q9UIF9
VYRGLQPLPGGQDSQ	GPR25	176	O00155
YQVQGPRPVLGGSFL	FBXO10	376	Q9UK96
VTGRVLPAPILQYGG	AGO1	406	Q9UL18
LPAPILQYGGRNRAI	AGO1	411	Q9UL18
VTQLPAAPRGRSLYG	ARSG	256	Q96EG1
GAGRLLQPIRATVPY	GLCCI1	56	Q86VQ1
PRALQEYQGGSSLPG	DISP2	96	A7MBM2
GGAYIAGVSPRLRLP	DISP2	716	A7MBM2
ILGPPAQYRLERGQA	CDAN1	1096	Q8IWY9
GPGGPNIQKLLYQRF	PPP1R13B	716	Q96KQ4
RVLQPPSILYGGRNK	AGO2	411	Q9UKV8
PRPQIYLAGLRGGKS	CFAP206	591	Q8IYR0
QPGRFQRALVQPGAY	QRICH2	506	Q9H0J4
YQPGLIAPGTKLRGS	QRICH2	811	Q9H0J4
IPNYQGPLGSRALGL	RAD54L	86	Q92698
LRPGLQYRTVSQTGP	ADARB2	136	Q9NS39
VPGNRPGSVIRVYGD	SPAG9	1181	O60271
PVPYFGRLQGGLTAR	LGALS4	191	P56470
IGRLYGPSLPGNLQY	MAMDC2	396	Q7Z304
GGAYVGPTQNRILRL	MAOA	66	P21397
LGGSYVGPTQNRILR	MAOB	56	P27338
VRYPIVTPSQRCGGG	BCAN	311	Q96GW7
VRPGGYTPQRALINP	DEPDC5	586	O75140
RYPILGIPQAHRGTG	MISP	6	Q8IVT2
LGGTVTLQLGYPPAR	IL11RA	101	Q14626
PQRLQGLRPVGSGAY	MAPK11	21	Q15759
YKEGADGLPQRPGRQ	LILRA4	256	P59901
LFATQNPPGLYGGRK	MDN1	1191	Q9NU22
NPPGLYGGRKVLSRA	MDN1	1196	Q9NU22
YQSGGRLRRPVNVPL	KCNA1	96	Q09470
NLPGGYSGSVKNRPT	MCPH1	601	Q8NEM0
YGRPGRGLRAATPVI	HIC1	171	Q14526
QSQGPGSGDTYRPKR	MAPK8IP1	146	Q9UQF2
GLQPRYGSRSAPKPQ	LRRC25	216	Q8N386
PGGAAARPRPQQRYS	LRFN1	691	Q9P244
YGLYSGPPGQQQRTR	IQSEC1	66	Q6DN90
LRGIQQLYGTPDGQP	MMP15	296	P51511
PGPGTGRGKYRTISQ	KCNH6	166	Q9H252
VGSVYRPNQNGRGLP	LOXL1	356	Q08397
PEQPLVRLRGGAYIG	LOXL2	321	Q9Y4K0
YQEGPVRLSPGRLQG	HLCS	291	P50747
RGVQLWRVPGPGQYL	LTK	106	P29376
PRRGDLQIYLVSPSG	PCSK6	551	P29122
ASGGQGFLYQPNPRL	PLXNB3	1136	Q9ULL4
STQGNGRPGRPSQYR	LCOR	106	Q96JN0
ALRLQGLRSQPTPGY	FAM234B	421	A2RU67
APLGYQDPVSLRRGS	EPS8L3	401	Q8TE67
RAGYSQRGAPLGPPR	HNRNPR	526	O43390
PVGRDGQGRSLYVPV	PEG10	656	Q86TG7
RREAPPSYGQLIAQG	LRP3	546	O75074
ILQQGGPVGFQPYRR	MARCHF6	611	O60337
QPSQGLGPRGYDPNR	GNL1	66	P36915
PGPRYNVNPKILRTG	ODF3	66	Q96PU9
LYGPNIGRPRKNVIA	HPSE2	301	Q8WWQ2
LLRPAQGRGAPISVY	PTPRU	611	Q92729
YPGTLQALGEPIRQG	OBSCN	5886	Q5VST9
EGLNRGPYVLGPADR	PLCB3	541	Q01970
PEGAVGRSLQPLYRS	DNASE2	71	O00115
CALRPAGIYGPGEQR	SDR42E1	181	Q8WUS8
RIAEFGGYIVQNPGP	LIG4	681	P49917
YGVNPRVGISPLRLA	DMRTA1	426	Q5VZB9
YGNRRVQPGELPFGA	ADGRF2	6	Q8IZF7
GLGCARPNKPGVYAR	LPA	2011	P08519
PIGIAIPFTARYRGN	DTHD1	236	Q6ZMT9
QLQYTGVQKPGPVRG	LTBP3	321	Q9NS15
TYGQVTGQLLRGPPG	FAM166B	36	A8MTA8
GSQYQPQRRRDPGAA	LOX	61	P28300
SLGGALTGRYLLPNP	MAST4	166	O15021
LRQNPLERLGTGGAY	MAST4	821	O15021
QVQAPARGTLGRVYP	MAPKBP1	971	O60336
LVLPSLYQGGRSGLP	KLHDC7B	286	Q96G42
LSYLNGVPEPSRGRG	KHDRBS1	271	Q07666
PGQAPRLLIYGASSR	IGKV3-20	61	P01619
PGQAPRLLIYGASTR	IGKV3-7	61	A0A075B6H7
QTLRQGVPLPGQYGG	HDAC9	356	Q9UKV0
KAPRLYPGGAENGRL	H6PD	496	O95479
RGRSPPYQLDSQGRL	BCAM	96	P50895
PLRKTYRENVGGPGA	BICRA	1386	Q9NZM4
SGGPVRVYSLPGREN	COCH	86	O43405
RRYNIKGRQQAGPGP	DHX37	6	Q8IY37
GPEYLAIGNLDPRGR	RUBCN	321	Q92622
RVLCPRNYGQLGGGP	SCAP	731	Q12770
IRQRTGILLYGPPGT	PEX1	871	O43933
GPERYQALLQLGGPR	CCDC103	116	Q8IW40
GPYVGQAGTATLPRN	CTNND1	191	O60716
NDPPQGLRAGLKRTY	DNAH5	4151	Q8TE73
RLLYPRFQSRGPQGV	MMAB	26	Q96EY8
PRDGRLYVPTNGSAL	PKD1	831	P98161
LQQPYLFSAVGRGRP	PKD1	1481	P98161
QVSHRRPPIGYRAGG	REEP4	176	Q9H6H4
PGRRYRNQPRGPVGN	KIF23	451	Q02241
ARLPGISQRVYPKGN	RP1	241	P56715
APGQPRGASRRQVTY	METTL24	61	Q5JXM2
QAGGGVLEQRPYRRG	KCNJ18	416	B7U540
LGNPANYPVSIRFGR	TRAPPC4	86	Q9Y296
AAGSTRQPIRGYVQP	SVIL	356	O95425
GLQGRPARRCYAVGP	HDHD5	26	Q9BXW7
GPESRYQTLPGRGLS	PLEKHA7	1006	Q6IQ23
LPYGAGRSRSNQLPK	SCG2	466	P13521
DEGIIRLYQRPGPGT	ST6GALNAC1	581	Q9NSC7
IREYPNSGPQLLGGI	SHPRH	356	Q149N8
GETRSPQGPRYNFGL	MSH4	21	O15457
LLTYRGGQAGPRGLA	WDR18	31	Q9BV38
LQSENGVLGLGPYPR	OXCT1	341	P55809
GLGCARPNKPGVYVR	PLG	781	P00747
GQPRLPGASNAEYRL	SOS1	476	Q07889
PPLSGYRAAQGPQRL	SPTY2D1	561	Q68D10
GPQRLPFPTGYKRQR	SPTY2D1	571	Q68D10
PRRGGPAGPYQQSQR	EARS2	106	Q5JPH6
IQQGCRAPPYLGRVG	AARS2	296	Q5JTZ9
SGGKPGINQTYRSPL	SETDB1	516	Q15047
VPILGYPRQLPGSQR	SLCO4A1	326	Q96BD0
LQGEREPGLLPYGSR	AFF1	621	P51825
RRVIPQQSGALYIPG	CLCA1	686	A8K7I4
YGLRPSRNPPDVGQL	TRAK2	816	O60296
AGLGRRPCPYEQAQG	UNC93B1	576	Q9H1C4
YVLLRQSNNGVPAGP	SEMA4G	796	Q9NTN9
LNYGLFQPPSRGRAG	SHANK3	51	Q9BYB0
GPGPRQYFLLSSQVG	EXT2	246	Q93063
RKPGEISYRIPQGGL	SRD5A2	171	P31213
PRYQRFPLGDGQSLL	PITPNM3	461	Q9BZ71
PENGALLRSERYQGP	ZNF839	296	A8K0R7
GLPVYAQSGEPRRLT	ZNF839	586	A8K0R7
RAEGSPPQRYILGIA	ZNF469	111	Q96JG9
SIIQLYPGGGPVRAA	TRMT6	226	Q9UJA5
IPSRYGTNNRIGQPR	SLC30A6	446	Q6NXT4
PGLPGVLSYVGAQER	ZNF415	21	Q09FC8
PYGGRGDPVNVSRVI	TGM1	311	P22735
GCGRPNRPGVYTNIS	PRSS21	261	Q9Y6M0
SDPRPQGQPRRGYTA	TASOR2	2046	Q5VWN6
GLLKPQTGGRNNYPT	VPS33A	451	Q96AX1
EDPGGYRLPLAQLGR	WDR25	71	Q64LD2
LRGGNRPNTGPLYTE	PLEKHA5	386	Q9HAU0
AGIYRCIGQGQRGPP	PTK7	296	Q13308
YNRTVGKGPGSRPQI	TNRC6A	1251	Q8NDV7